Publications
- An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart (R)2020 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate2019 | Faculty of Medicine in Hradec Králové
- Teriflunomidu position in the treatment of multiple sclerosis2018 | Faculty of Medicine in Hradec Králové
- Encephalitis with anti-NMDA receptor antibodies: paraneoplastic or non-paraneoplastic?2018 | Faculty of Medicine in Hradec Králové
- Lymphocytes in the treatment with interferon beta-1 b2017 | Faculty of Medicine in Hradec Králové
- Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome2016 | Faculty of Medicine in Hradec Králové
- Glatiramer acetate and three case reports2016 | Faculty of Medicine in Hradec Králové
- The diagnosis and treatment of multiple sclerosis2015 | Faculty of Medicine in Hradec Králové
- Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 20212023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
Loading network view...
